Institutional coverage just initiated a 'BUY' rating. Watch the video breakdown to see why: ✅ RM 9.8M Net Cash (Fortress balance sheet) ✅ ZERO Dilution (Funding their own ESG SaaS & China expansion) ✅ High-Margin Tech (~26x Forward P/E) 👇 Read the full institutional report via the official SGX portal: https://www.sgx.com/research-education/analyst-research?value=Lms&category=26 @LMS SGX
$AJJ Medtech(584.SI)$ One chart on AJJ Medtech (SGX: 584). Morningstar’s quantitative model currently shows 4-Star, ~32% undervaluation, 75% 3Y revenue growth, and a Small Growth classification. For a micro-cap name, the key point is that AJJ is starting to show up on the market’s small-growth medtech radar. @Tiger_SG@新加坡交易所集团@Daily_Discussion
$扬子江船业(BS6.SI)$ Shipbuilding is quietly entering another cycle. Yangzijiang now has an order backlog of US$22.4bn, with shipyards fully booked until 2029. The order mix is also changing. About 80% of the orderbook now comes from clean-energy vessels such as LNG and dual-fuel ships. The investment story is quite simple: visibility of earnings + 5–6% dividend yield. Among SGX industrial companies, few have this level of order visibility.
$携程网(TCOM)$ Trip.com’s latest numbers don’t show a slowdown. Revenue grew over 20%, with double-digit growth across hotels and tickets. International revenue is still up more than 60%.
$赛富时(CRM)$ The quarter was largely inline. Growth is still around 10%, and SaaS multiples remain compressed. The interesting part is AgentForce. ARR is up nearly 170%, with expansion mostly from existing customers.
$亚马逊(AMZN)$ This quarter wasn’t about retail. AWS growth re-accelerated above 23%, with backlog rising alongside it. Retail supports margins, but AWS is driving growth again.